Keywords: PC; prostate cancer; mPC; metastatic prostate cancer; ADT; androgen deprivation therapy; CRPC; castration resistant prostate cancer; mCRPC; metastatic CRPC; SNP; single nucleotide polymorphism; CNV; copy number variation; AR; androgen receptor; CTC; circu
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: cfDNA; circulating free DNA; CK; pan-cytokeratin; CT; competed tomography; CTC; circulating tumor cells; DAPI; 4 6-diamidino-2-phenylindole; DFS; disease-free survival; EDTA; ethylenediaminetetraacetic acid; EGFR; epidermal growth factor receptor; EpCAM;
Keywords: ADCC; antibody-dependent cell-mediated cytotoxicity; AKT; protein kinase B; ATP; adenosine triphosphate; cfDNA; circulating free DNA; CISH; chromogenic in-situ hybridization; CTC; circulating tumor cells; EGFR; epithelial growth factor receptor; EMT; epit
Keywords: Circulating tumour cells; Circulating free DNA; Circulating free RNA; Personalised cancer therapy; Colorectal cancer;
Evaluation of commercial kits for purification of circulating free DNA
Keywords: Circulating free DNA; Circulating tumor DNA; Liquid biopsy; Biomarker;
Plasma epidermal growth factor receptor mutation testing with a chip-based digital PCR system in patients with advanced non-small cell lung cancer
Keywords: ARMS; amplification refractory mutation system; BEAMing; beads, emulsions, amplification and magnetics; cfDNA; circulating free DNA; CI; confidence interval; ddPCR; droplet digital polymerase chain reaction; dPCR; digital polymerase chain reaction; EGFR;
Circulating free DNA in the era of precision oncology: Pre- and post-analytical concerns
Keywords: Circulating free DNA; Characterization; Extraction; Validation; Interpretation;
A Minimally-invasive Blood-derived Biomarker of Oligodendrocyte Cell-loss in Multiple Sclerosis
Keywords: Relapsing-remitting multiple sclerosis; Oligodendrocyte; Cuprizone; Human patients; Circulating free DNA; Biomarker discovery
Direct detection of circulating free DNA extracted from serum samples of breast cancer using locked nucleic acid molecular beacon
Keywords: cfDNA; circulating free DNA; PCR; polymerase chain reaction; UHRF1; Ubiquitin-like with PHD and ring finger domains 1; BC; breast cancer; LNA-MB; locked nucleic acid modified molecular beacon; PNA; peptide nucleic acid; NCBI; National Center for Biotechno
Use of a new generation of capillary electrophoresis to quantify circulating free DNA in non-small cell lung cancer
Keywords: Circulating free DNA; Non-small cell lung cancer; Early diagnosis;
Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer
Keywords: Circulating free DNA; Lung cancer; Prognosis; Early diagnosis; Biomarker; PCR
Circulating free DNA in plasma or serum as biomarker of carcinogenesis: Practical aspects and biological significance
Keywords: Circulating free DNA; Molecular epidemiology; Carcinogenesis; Biomarker